Bone is the most common site of metastasis for breast cancer. Bone metastasis significantly
affects both quality of life and survival of the breast cancer patient. Clinically, complications …

OBJECTIVE. FDG PET/CT affects the management of patients with breast cancer in multiple
settings, including initial staging, treatment response assessment, and evaluation of …

Background Integrated PET/MRI is a promising modality for breast assessment. The most
frequently used tracer, fluorine 18 (18F) fluorodeoxyglucose (FDG), is applied for whole …

Immune checkpoint inhibitors (ICIs) are now commonly used to treat patients with metastatic
malignant melanoma. Although concerns have been raised that the inflammatory response …

PET/CT molecular imaging has been imposed in clinical oncological practice over the past
20 years, driven by its two well-grounded foundations: quantification and radiolabeled …

Breast cancer prognosis is steadily improving due to early detection of primary cancer in
screening programs and revolutionizing treatment development. In the metastatic setting …

Breast cancer is the most common cancer among women in the United States and the
second leading cause of cancer-related deaths; approximately 12.9% of women will be …

Purpose To provide an organized, international, state-of-the-art, and multidisciplinary
guideline, led by experts of two nuclear medicine societies (EANM and SNMMI) and …

Simple Summary Artificial intelligence (AI) has seamlessly integrated into the medical field,
especially in diagnostic imaging, thanks to ongoing AI advancements. It is widely used in …

This study aimed to compare CE-CT and 2-[18F] FDG-PET/CT for response monitoring
metastatic breast cancer (MBC). The primary objective was to predict progression-free and …